EyePoint · 2 weeks ago
Microbiologist II
EyePoint is an ophthalmology company committed to improving the lives of patients with serious retinal diseases by developing and commercializing innovative therapeutics. The Microbiologist II will be responsible for monitoring cleanroom environments, managing samples, and conducting various microbiological tests to ensure quality control.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Monitoring ISO classified cleanroom environments
Sample Management
Gathering Critical Utility Samples
Data Trending, Excursion Writing
USP Endotoxin Extraction and LAL Testing - SOP and Form Technical Writing and Revision
Growth Promotion USP - Water Testing, LAL, TOC, Bioburden, Conductivity
Testing of Biological Indicators
Cleanroom Gowning
Microbial Enumeration
Disinfection and Sterilization of Tools and Equipment (Steam and Cold)
Depyrogenation
Coordination with CTLs
Isolation of Bacteria, Mold and Yeast
Developing and Executing additional assays and activities as needed
Qualification
Required
Bachelor's Preferred, a combination of education and experience can be used as a substitute
Minimum of 3 years of Quality Control/Microbiology experience
Aseptic Technique
Working in GMP Regulated Industry
Good Documentation Practices
ISO 14644-1
ISO 11737, ISO 11137 (Gamma)
Sharps Safety
Pipetting
Streaking for Isolation
Preferred
Preferred Field of Study: Science (Biology, Microbiology, Virology, Chemistry)
Company
EyePoint
EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of people with serious retinal diseases.
H1B Sponsorship
EyePoint has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (4)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$803.8MKey Investors
Silicon Valley BankOcumension TherapeuticsEssex Woodlands Healthcare Partners
2025-10-14Post Ipo Equity· $150M
2023-12-05Post Ipo Equity· $215.9M
2022-03-09Post Ipo Debt· $45M
Leadership Team
Recent News
Clinical Trials Arena
2026-01-11
2025-12-17
2025-12-16
Company data provided by crunchbase